Resynchronization of Separated Rat Cardiomyocyte Fields With Genetically Modified Human Ventricular Scar Fibroblasts
Author(s) -
Daniël A. Pijnappels,
John van Tuyn,
Antoine A.F. de Vries,
Robert W Grauss,
Arnoud van der Laarse,
Dirk L. Ypey,
Douwe E. Atsma,
Martin J. Schalij
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.712935
Subject(s) - medicine , intracellular , cardiac resynchronization therapy , heart failure , gene expression , connexin , stimulation , gap junction , microbiology and biotechnology , gene , biology , genetics , ejection fraction
Nonresponse to cardiac resynchronization therapy is associated with the presence of slow or nonconducting scar tissue. Genetic modification of scar tissue, aimed at improving conduction, may be a novel approach to achieve effective resynchronization. Therefore, the feasibility of resynchronization with genetically modified human ventricular scar fibroblasts was studied in a coculture model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom